Britt Gambino

The American College of Physicians (ACP) released a statement supporting an “immediate ramping up of supply for distribution of COVID-19 vaccines equitably among and within countries in need.”

Short-term exposure to air pollution as a result of wildfire may be associated with increased health care use among patients with atopic dermatitis and itch.

Although asthma and autoimmune disease are thought to have mutually exclusive pathogeneses, they both result from a dysregulated immune system.

Treatment with dupilumab may help patients with uncontrolled, moderate to severe asthma achieve “clinical asthma remission.”

Weekly dupilumab improved disease-specific health-related quality of life and symptom burden in adolescent and adult patients with eosinophilic esophagitis.

A higher neutrophil count predicted worse disease course and higher long-term mortality in patients with systemic sclerosis-related interstitial lung disease.

The 3-month Asthma Impairment and Risk Questionnaire (AIRQ™) demonstrated a similar ability to differentiate asthma control as the 12-month AIRQ.

The effect of coronavirus disease 2019 (COVID-19) on patients with food allergy and their parents and caregivers is substantial.

Researchers conducted a retrospective analysis of patients with COPD who were hospitalized and mechanically ventilated.

In the first 30 days following an exacerbation of chronic obstructive pulmonary disease, there is an increased risk of cardiovascular adverse events.

In patients with type 2 asthma, dupilumab was associated with significantly lower annualized outpatient asthma exacerbation rates and lower total number of days using systemic corticosteroids.

Researchers evaluated the association between osteoporosis and vertebral fragility fractures with cardiovascular calcification in patients with chronic obstructive pulmonary disease.

Expired or previously used and sterilized N95 respirators can be used when new N95 respirators are unavailable during the COVID-19 pandemic.

The Theraflu Home FluTest, a novel rapid influenza diagnostic test, demonstrated good sensitivity and specificity for both influenza A and B viruses.

Treatment with dexamethasone resulted in lower rates of 28-day mortality in patients hospitalized with COVID-19 who received invasive mechanical ventilation but not in those who received no respiratory support.

Researchers evaluated the effect of anti-acid treatment on disease progression in systemic sclerosis interstitial lung disease.

Acromegaly is associated with an increased risk for mortality from vascular and respiratory disease, but not malignant disease.

In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.

Patients with asthma and COPD appear to have increased their adherence to inhaler medications in the wake of the COVID-19 pandemic.

Tobacco smoke exposure inhibited the therapeutic benefit of the cystic fibrosis transmembrane conductance regulator modulators in pediatric patients.

Compared with white patients, black patients with screen-detected cancers had a lower calculated lung cancer risk, despite having a significantly higher mean 6-year lung cancer risk.

Patients with COVID-19 pneumonia may present with 2 distinct phenotypes, each warranting distinct treatments.

Fibrosis indicators, including lymphocyte count and C-reactive protein, may be used as early warning signs of poor prognosis in patients with COVID-19.

Right atrial conduit phase emptying may predict the risk for adverse clinical events in pediatric patients with pulmonary arterial hypertension.

Routine testing for non-SARS-CoV-2 pathogens is unlikely to provide clinical benefit unless a positive result would alter the disease management.

Chronic obstructive pulmonary disease is associated with a greater than 5-fold increased risk for severe coronavirus disease 2019 infection.

A joint statement issued by the Society of Critical Care Medicine and several other medical societies has advised against the use of 1 ventilator for multiple patients.

In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.

The leadership of American Thoracic Society recently released a statement, as well as 2 fact sheets, in response to the COVID-19 outbreak.

The annual meeting of the American Academy of Allergy, Asthma & Immunology has been canceled, but the research will still be shared and promoted.